PUBLIC COMPANY
save6S Pharma LLC
founded 2023 · 5 employees · Belle Mead, NJ, USupdated 2mo ago
6S Pharma is an early-stage pharmaceutical startup developing 505(b)(2) repurposed drugs and complex generics across a preclinical pipeline that targets oral mucositis, diabetic foot ulcers, burns, uterine fibroids, Sjogren's syndrome, macular degeneration, leptomeningeal disease, and gastric ulcers. The company is preparing IND filings for two of its products and has out-licensed one complex generic formulation.
community read0 votes
pipeline
8
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(8)
pipeline depth8 products
8Preclinical
Preclinical
6SP-001
Oral Mucositis
Preclinical6SP-002
Diabetic Foot Ulcers
Preclinical6SP-003
Burns
Preclinical6SP-2405
Uterine Leiomyoma (Uterine Fibroids)
Preclinical6SP-2406 ER
Sicca Syndrome (Sjogren)
Preclinical6SP-2407
Macular Degeneration
Preclinical6SP-2408
Leptomeningeal Disease (Neoplastic Meningitis, Leptomenin…
Preclinical6SP-2409
Gastric Ulcers
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that